March 23-25, 2027
Pre-Conference Workshops on March 22, 2027Gaylord National Resort and Convention Center | National Harbor, MD Kim Burlison, MPPSenior Director, Head US Market Access at Orchard TherapeuticsSpeaker
Profile
Kimberly Burlison is a senior market access leader with deep experience navigating the intersection of commercialization, payer strategy, and patient access across the biotechnology and managed care sectors. As Senior Director and Head of U.S. Market Access at Orchard Therapeutics, Kim leads U.S. market access strategy and execution for Lenmeldy, a first-in-class gene therapy for metachromatic leukodystrophy (MLD), a rare and life-threatening pediatric disease.
Agenda Sessions
Accelerating Speed to Treatment – Mastering Payer Dynamics and Reimbursement Strategy
, 11:30amView Session